DK1066287T3 - Azatricykliske forbindelser - Google Patents

Azatricykliske forbindelser

Info

Publication number
DK1066287T3
DK1066287T3 DK99908541T DK99908541T DK1066287T3 DK 1066287 T3 DK1066287 T3 DK 1066287T3 DK 99908541 T DK99908541 T DK 99908541T DK 99908541 T DK99908541 T DK 99908541T DK 1066287 T3 DK1066287 T3 DK 1066287T3
Authority
DK
Denmark
Prior art keywords
hydrogen
substituent
sigma
species characterized
nitrogen
Prior art date
Application number
DK99908541T
Other languages
Danish (da)
English (en)
Inventor
Peter Anthony Crooks
Niranjan Madhukar Deo
Original Assignee
Targacept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targacept Inc filed Critical Targacept Inc
Application granted granted Critical
Publication of DK1066287T3 publication Critical patent/DK1066287T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/10—Biofuels, e.g. bio-diesel

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK99908541T 1998-04-02 1999-02-26 Azatricykliske forbindelser DK1066287T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/054,179 US5986100A (en) 1998-04-02 1998-04-02 Pharmaceutical compositions and methods for use
PCT/US1999/004324 WO1999051601A1 (en) 1998-04-02 1999-02-26 Azatricyclic compounds

Publications (1)

Publication Number Publication Date
DK1066287T3 true DK1066287T3 (da) 2004-01-19

Family

ID=21989278

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99908541T DK1066287T3 (da) 1998-04-02 1999-02-26 Azatricykliske forbindelser

Country Status (14)

Country Link
US (2) US5986100A (pt)
EP (1) EP1066287B1 (pt)
JP (1) JP2002510689A (pt)
KR (1) KR100613050B1 (pt)
AT (1) ATE248839T1 (pt)
AU (1) AU2794899A (pt)
BR (1) BR9907191A (pt)
CA (1) CA2317570A1 (pt)
DE (1) DE69910993T2 (pt)
DK (1) DK1066287T3 (pt)
ES (1) ES2205778T3 (pt)
MX (1) MXPA00009624A (pt)
PT (1) PT1066287E (pt)
WO (1) WO1999051601A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093724A (en) * 1998-08-18 2000-07-25 Ucb, S.A. Muscarinic agonists and antagonists
CA2470567A1 (en) * 2001-12-14 2003-06-26 Targacept, Inc. Methods and compositions for treatment of central nervous system disorders
US20030162770A1 (en) 2002-02-22 2003-08-28 Davis Bonnie M. Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
US7897766B2 (en) * 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
AU2012203831B2 (en) * 2006-11-06 2013-12-19 Abbvie Bahamas Ltd Azaadamantane derivatives and their uses as nicotinic acetylcholine receptors ligands
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
US8163914B2 (en) 2007-03-23 2012-04-24 Abbott Laboratories Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof
EP2139891B1 (en) * 2007-03-23 2012-09-05 Abbott Laboratories 4-substituted azaadamantane derivatives and methods of use thereof
KR20130108586A (ko) 2010-09-23 2013-10-04 애브비 인코포레이티드 아자아다만탄 유도체의 일수화물
TWI773657B (zh) 2015-12-18 2022-08-11 美商亞德利克斯公司 作爲非全身ｔｇｒ５促效劑之經取代之4-苯基吡啶化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2022886A1 (en) * 1989-08-08 1991-02-09 Raymond Baker Substituted pyridines, their preparation, formulations and use in dementia
US5110933A (en) * 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
EP0492903A1 (en) * 1990-12-21 1992-07-01 MERCK SHARP & DOHME LTD. Substituted pyrazines, pyrimidines and pyridazines for use in the treatment of glaucoma
WO1995003306A1 (en) * 1993-07-22 1995-02-02 E.I. Du Pont De Nemours And Company Arthropodicidal azacyclic heterocycles
US5510355A (en) * 1994-09-06 1996-04-23 Bencherif; Merouane Depolarizing skeletal muscle relaxants
WO1996036637A1 (en) * 1995-05-17 1996-11-21 R.J. Reynolds Tobacco Company Pharmaceutical compositions for prevention and treatment of central nervous system disorders
US5583140A (en) * 1995-05-17 1996-12-10 Bencherif; Merouane Pharmaceutical compositions for the treatment of central nervous system disorders
US5684159A (en) * 1995-05-30 1997-11-04 Rhone-Poulenc Rorer S.A. L-tartaric acid salt of a (1R) diastereomer of a 2-azadihydroxybicyclo 2.2.1!heptane compound and the preparation of 2-azabicyclo 2.2.1!heptane compounds

Also Published As

Publication number Publication date
DE69910993D1 (de) 2003-10-09
US6211372B1 (en) 2001-04-03
PT1066287E (pt) 2004-01-30
CA2317570A1 (en) 1999-10-14
DE69910993T2 (de) 2004-07-22
AU2794899A (en) 1999-10-25
EP1066287A1 (en) 2001-01-10
BR9907191A (pt) 2000-12-26
KR100613050B1 (ko) 2006-08-25
WO1999051601A1 (en) 1999-10-14
EP1066287B1 (en) 2003-09-03
MXPA00009624A (es) 2005-06-20
US5986100A (en) 1999-11-16
ES2205778T3 (es) 2004-05-01
KR20010052172A (ko) 2001-06-25
ATE248839T1 (de) 2003-09-15
JP2002510689A (ja) 2002-04-09

Similar Documents

Publication Publication Date Title
HK1072770A1 (en) Bicyclic compound
AU2003222450A1 (en) Stabilized ascorbic acid derivatives
CA2418770A1 (en) Acylacetonitrile compound, process for preparation thereof, and miticide containing the same
EP1090922A3 (en) Organophosphorous composition, method of producing organophosphorous compound, polyester composition and method of producing the same
DK1066287T3 (da) Azatricykliske forbindelser
TWI265969B (en) Liquid-crystalline medium having a high birefringence and improved UV stability
ATE240331T1 (de) Azatricyclo(3.3.1.1)decanderivate und diese enthaltende phrmazeutische zubereitungen
EP0945764A3 (en) Photoresist composition
SG104967A1 (en) Electron withdrawing group-containing metal compound
MY133299A (en) Skin moisturizing composition comprising a choline salt
WO1999009965A3 (en) Anti-inflammatory agent
WO2002083616A1 (fr) DERIVE D'ACIDE GRAS φomega;-ARYLE α-SUBSTITUE
ATE260285T1 (de) Geschützte phenylalkylsilane
EP0953605A3 (en) Flow improved polycarbonate composition
CA2042673A1 (en) Acetyl-tri- and tetramethyl-octahydronaphthalenes and fragrance compositions containing the same
CA2191947A1 (en) Pirydyl Imidazole Derivatives and Processes for the Preparation Thereof
ATE265854T1 (de) Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs
MXPA03002081A (es) Accesorios quirales de 4-ciclohexil-1, 3, 2-oxazaborolidina.
HUP0002314A2 (hu) Glicidil-észter és glicidil-észtert tartalmazó hőre keményedő gyantakészítmény
EP0816349A4 (en) NOVEL CLATHRATE COMPOUND, MANUFACTURING METHOD AND COATING COMPOSITION CONTAINING SAID NEW CLATHRATE COMPOUND
EP1101767A3 (en) Oligosiloxane and method of preparing same
TWI256383B (en) Anthraquinone compound
EP0454874A4 (en) Thia- and/or selenafulvalenyl compound
TW270112B (en) Novel compounds capable of lowering blood-lipid activity and its production process and its novel intermediates
EP0753514A4 (en) ALKYLENEDIAMINE DERIVATIVES